Effect of ploidy, recruitment, environmental factors, and tamoxifen treatment on the expression of sigma-2 receptors in proliferating and quiescent tumour cells

British Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 925-933

  Al Nabulsi, I ^a   Mach, R H ^a   Wang, L M ^a   Wallen, C A ^a   Keng, P C ^b   Sten, K ^a   Childers, S R ^a   Wheeler, K T ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Biological factors; Physiological factors; Proliferative tumour cells; Quiescent tumour cells; Sigma 2 receptors

Indexed keywords

OPIATE RECEPTOR; TAMOXIFEN; TUMOR MARKER;

ANIMAL CELL; ARTICLE; BRAIN TUMOR; BREAST ADENOCARCINOMA; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CELL TYPE; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PH; PLOIDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECIES DIFFERENCE; TUMOR CELL;

ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BRAIN NEOPLASMS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; PLOIDIES; RATS; RECEPTORS, SIGMA; TAMOXIFEN; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032751660     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690789     Document Type: Article

References (34)

1. por correlation. Semin Rad Oncol 2: 62-66
2. Begg AC, Hofland I, Van Glabbeke M and Horiol JC (1992) Predictive value of potential doubling time for radiotherapy of head and neck tumor patients results from the EORTC cooperative trial 22851. Semin Rad Oncol 1: 22-25
3. por! Int J Radiat Oncol Biol Phys 32: 1539-1541
4. Bem WT, Thomas GE, Mamone JY, Homan SM, Levy BK, Johnson FE and Coscia CJ (1991) Overexpression of σ receptors in nonneural human tumours. Cancer Res 51: 6558-6562
5. Berthois Y, Katzenellenhogen JA and Katzenellenbogen BS (1986) Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture. Proc Natl Acad Sci USA 83: 2496-2500
6. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254
7. Chaval P, Courdi A, Gioanni J, Vallicioni J, Santini J and Demard F (1989) The labeling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 14: 231-237
8. Corro R, Giaretti W, Sanguinet G. Geido E, Oreechia R, Guenzi M, Margarino G, Bacigalupo A, Garaventa G, Barbieri M and Vitale V (1995) In vivo cell kinetics in head and neck squamous cell carcinomas predicts local control and helps guide radiotherapy regimen. J Clin Oncol 13: 1843-1850
9. Dong H, Bertler C, Schneider F and Ritter MA (1997) Assessment of cell proliferation by AgNOR scores and Ki-67 labeling indices and a comparison with potential doubling times. Cytometry 28: 280-288
10. Dressler LG (1993) DNA flow cytometry measurements and their clinical relevance in node negative breast cancer. Recent Results in Cancer Res 127: 61-69
11. Eckert RL and Katzenellenbogen BS (1982) Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells. Cancer Res 42: 139-144
12. Grogan TM, Lippman SM, Spier CM, Slymen DJ, Rybski JA, Rangle CS, Richter LC and Miller TP (1988) Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67. Blood 71: 1157-1160
13. por) be compared between laboratories? A quality control study. Cytometry 19; 154-163
14. Hedley DW, Shankey TV and Wheeless LL (1993a) DNA cytometry consensus conference. Cytometry 14: 471
15. Hedley DW, Clark GM, Cornelisse CJ, Killander D, Kute T and Merkel D (1993b) Consensus review of the clinical utility of DNA cytometry in carcinoma of the breast. Cytometry 14: 482-485
16. Hellwell SB, Bruce A, Feinstein G, Orringer J, Williams W and Bowen WD (1994) Rat liver and kidney contain high densities of σ, and σ, receptors: characterization by ligand binding and photoaffinity labeling. Eur J Pharmacol Mol Pharmacol Sec 268: 9-18
17. Katzenellenhogen BS. Norman MJ, Eckert RL, Peltz SW and Mangel WF (1984) Bioactivities, estrogen receptor interactions, and plasminogen activator-inducing activities of tamoxifen and hydroxytamoxifen isomers in MCF-7 human breast cancer cells. Cancer Res 44: 112-119
18. Li CKN (1982a) The glucose distribution in 9L rat brain multicell tumour spheroids and its effect on cell necrosis. Cancer 50: 2066-2073
19. Li CKN (1982b) The role of glucose in the growth of 9L multitumour spheroids. Cancer 50: 2074-2078
20. 2, receptors as potential biomarkers of proliferation in breast cancer. Cancer Res 57: 156-161
21. McGuire WL and Dressler LG (1985) Emerging impact of flow cytometry in predicting recurrence and survival in breast cancer patients. J Natl Cancer Inst 75: 405-410
22. por). Int J Radiat Oncol Biol Phys 31: 833-840
23. Shackney SE, McCormack GW and Cuchural GJ (1978) Growth rate patterns of solid tumours and their relation to responsiveness to therapy. An analytic review. Ann Int Med 89: 107-121
24. Thames, HD, Peters LJ, Withers, HR and Fletcher GH (1983) Accelerated fractionation vs hyperfractionation: rationale for several treatments per day. Int J Radiat Oncol Biol Phys 9: 127-138
25. por in cancer of the uterine cervix: correlation between two laboratories and preliminary clinical results. Int J Radiat Oncol Biol Phys 32: 1319-1329
26. Vilner BJ and Bowen WD (1992) Characterization of sigma like binding properties of NB41A3, S-20Y, and NIE-115 neuroblastoma, C6 glioma, and NG 108-15 neuroblastoma-glioma hybrid cells: further evidence for sigma-2 receptors. In Multiple Sigma and PCP Receptor Ligands: Mechanisms for Neuromodulation and Neutroprotection, JM Kamenka and EF Domino (eds.) pp 341-353. NPP Books: Ann Arbor, MI
27. Vilner BJ, John CS, and Bowen WD (1995) Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumour cell lines. Cancer Res 55: 408-413
28. Walker JM, Bowen WD, Walker FO, Matsumoto RR, De Costa B and Rice KR (1990) Sigma receptors: biology and function. Pharmacol Rev 42: 355-402
29. Wallen CA, Michaelson SM and Wheeler KT (1980) Evidence for an unconventional radiosensitivity of rat 9L subcutaneous tumors. Radiat Res 84: 529-541
30. Wallen CA, Higashikubo R and Dethlefsen LA (1984a) Murine mammary tumor cells in vitro. I. The development of a quiescent state. Cell Tissue Kinet 17: 65-77
31. Wallen CA, Higashikubo R and Dethlefsen LA (1984b) Murine mammary tumor cells in vitro II. Recruitment of quiescent cells. Cell Tissue Kinet 17: 79-89
32. Wheeler KT and Wallen CA (1980) Is cell survival a determinant of the in situ response of 9L tumours? Br J Cancer 41: Suppl. IV 299-303
33. Wheeler KT, Hickman R, Nelson GB, Moore SK and Wallen CA (1992) Relationship between DNA damage, DNA repair, metabolic state and cell lethality. Radiat Environ Biophys 31: 101-115
34. Zhang H and Wheeler KT (1994) Radiation-induced DNA damage in tumors and normal tissues. II. Influence of dose, residual DNA damage and physiological factors in oxygenated cells. Radiat Res 140: 321-326